A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National ...

This story was originally published in Uncloseted Media, an LGBTQ focused investigative news outlet. Back in April, ...

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, ...

In the wake of a fatal shooting at the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta on ...

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...

Unit 371 at Illinois Masonic Hospital was a major treatment center for AIDS and inspired similar wards in Chicago and across ...

Thousands of Kenyans are set to benefit from the roll-out of Lenacapavir injectable HIV preventive drug. The drug is the ...

Access is the central tenet to the success of lenacapavir as a form of preexposure prophylaxis (PrEP), according to Jeremiah Johnson, the executive director of PrEP4All and Mitchell Warren, the ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

When it comes to HIV prevention, the U.S. Supreme Court appeared to back up the task force with its July 11 ruling in Kennedy ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future ...